Thrombotic complications with SARS-CoV-2 infection in patients with cancer on high-risk therapies: Data from the COVID-19 and Cancer Consortium (CCC19)

• Published in: Journal of clinical oncology Vol. 39; no. 15_suppl; p. e18788
• Main Authors: Gulati, Shuchi, Shah, Surbhi, Kulkarni, Amit, Desai, Aakash, Fu, Julie, Zon, Rebecca, Kumar, Vaibhav, Hsu, Chih-Yuan, Hwang, Clara, Doroshow, Deborah Blythe, Akpan, Imo, Girard, Jennifer, Yu, Peter Paul, McKay, Rana R., Bakouny, Ziad, Connors, Jean, Shah, Dimpy P., Warner, Jeremy Lyle, Rosovsky, Rachel Pam Greenerger, Grivas, Petros
• Format: Journal Article
• Language: English
• Published: 20.05.2021

Abstract only e18788 Background: Patients (pts) with cancer have a high risk of venous thromboembolic (VTE) complications, further enhanced by anti-cancer treatments, specifically hormonal therapies, targeted therapies (VEGF inhibitors, other TKIs) and immune checkpoint inhibitors (ICIs). We hypothe...